Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI) (110744-73-5)

Identification
Name:	Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Synonyms:	Hexadecanamide,N-[1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,[1S-[1R(S),2R,3S,12Z]]-; Acanthacerebroside C
CAS:	110744-73-5
Molecular Formula:	C44H85 N O10
Molecular Structure:
Properties
Safety Data

Other Product

Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Hexadecanamide,N-[(1S,2S,3R,8Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-8-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Pentadecanamide,N-[(1S,2S,3R,8Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-8-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Hexadecanamide,N-[(1S,2S,3R)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxyheneicosyl]-2-hydroxy-, (2R)-(9CI)
Tetracosanamide,N-[(1S,2S,3R)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxypentadecyl]-2-hydroxy-, (2R)-(9CI)
Tetracosanamide,N-[(1S,2S,3R)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-14-methylpentadecyl]-2-hydroxy-,(2R)-
Hexadecanamide,N-[(1S,2R,3E,7Z)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-,(2R)-
Hexadecanamide,N-[(1S,2R,3E,7E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-,(2R)-
Dodecanamide,N-[(1S,2R,3E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecenyl]-12-[(2,4,6-trinitrophenyl)amino]-(9CI)
Hexadecanamide,N-[(1S,2R,3E,7E,9E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-8-methyl-3,7,9-heptadecatrien-1-yl]-2-hydroxy-,(2R)-
Hexadecanamide, N-[1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-4,8-octadecadienyl]-2-hydroxy-(9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-14-methylpentadecyl]-2-hydroxy-,(2R)- (9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-13-methyltetradecyl]-2-hydroxy-,(2R)- (9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-15-methylhexadecyl]-2-hydroxy-,(2R)- (9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-16-methylheptadecyl]-2-hydroxy-,(2R)- (9CI)
Tricosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-13-methyltetradecyl]-2-hydroxy-,(2R)- (9CI)
Tricosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-14-methylpentadecyl]-2-hydroxy-,(2R)- (9CI)
15-Tetracosenamide,N-[(1S,2S,3R,5E)-1-[(b-D-galactopyranosyloxy)methyl]-2,3-dihydroxy-5-heptadecenyl]-2-hydroxy-,(2R,15Z)- (9CI)
Tetracosanamide, N-[(1S,2S,3R)-1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxy-15-methylhexadecyl]-2-hydroxy-,(2R)-
Docosanamide,N-[(1S,2R,3E,9E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3,9-heptadecadienyl]-2-hydroxy-,(2R)- (9CI)